BioLargo's market cap is currently $49.05M. The company's EPS TTM is $-0.02; its P/E ratio is -12.25; BioLargo is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
